Gao, Lin-rui
Wang, Xin
Han, Weiming
Deng, Wei
Li, Chen
Wang, Xiaomin
Zhao, Yidian
Ni, Wenjie
Chang, Xiao
Zhou, Zongmei
Deng, Lei
Wang, Wenqing
Liu, Wenyang
Liang, Jun
Zhang, Tao
Bi, Nan
Wang, Jianyang
Zhai, Yirui
Feng, Qinfu
Lv, Jima
Li, Ling
Xiao, Zefen http://orcid.org/0000-0003-0503-6814
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2016L04)
Article History
Received: 22 July 2020
Accepted: 8 September 2020
First Online: 22 September 2020
Ethics approval and consent to participate
: Institutional review board approval was obtained for the 3JECROG P-02 trial from the ethical committee of the Chinese Academy of Medical Sciences (reference number 17–113/1369). The 3JECROG P-02 trial is published under NCT03308552 on ExternalRef removed. Written informed consent is obtained from all participants.
: Not applicable.
: The authors have declared that no competing interests exist.